Your Coronavirus Update
A newsletter by Medium Coronavirus Blog
February 3, 2021 • 2 min read • View in browser
The Latest: Does it matter which vaccine you get?
Dear Reader,
The vaccine rollout is happening worldwide with varied success. But the promise of adding more vaccines to the arsenal is really encouraging news. AstraZeneca and University of Oxford released data today showing their vaccine cuts down on transmission. Great!
As I wrote earlier this week, some may wonder what happens if some vaccines are more effective than others. On a population level, researchers have found that it makes sense to vaccinate with whatever is available (given it’s safe and effective).
But what about on a personal level? Epidemiologist Gideon Meyerowitz-Katz puts it really well, saying: Forget about society for a moment. What’s important to you? It’s probably not getting really sick from Covid-19 or dying from it. These vaccines, which are safe, prevent that from happening. Here’s his advice:
“The choice, at least in my mind, is relatively simple. Take the vaccine you are offered. If it’s been approved, it’s pretty safe, and is almost certain to make you far safer against the things you really care about than you would be otherwise.”
Be well,
Alexandra Sifferlin
Editor, Medium Coronavirus Blog
If you’ve been enjoying this newsletter, please tell a friend! Forward this email and let them know they can sign up to receive regular updates from our Coronavirus Team.
A quick Q&A: What happens if there are multiple vaccines with varying effectiveness?
In a recent modeling study, researchers argue that in most pandemic situations you should give people whatever vaccines are available even if there are efficacy differences. Vaccinating people with whichever vaccine is available will prevent hospitalizations and health care costs. While some Covid-19 vaccines might have higher reported efficacy rates than others, overall, the currently available vaccines and vaccines that may be approved for use (such as Johnson & Johnson’s) all look effective and safe.
The New York Times
